APA (7th ed.) Citation

Kang, S. H., Choi, J., Yim, H. J., Jung, Y. K., Yim, S. Y., Lee, Y., . . . Byun, K. S. (2026). Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study. Cancers, 18(1), 120. https://doi.org/10.3390/cancers18010120

Chicago Style (17th ed.) Citation

Kang, Seong Hee, et al. "Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study." Cancers 18, no. 1 (2026): 120. https://doi.org/10.3390/cancers18010120.

MLA (9th ed.) Citation

Kang, Seong Hee, et al. "Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study." Cancers, vol. 18, no. 1, 2026, p. 120, https://doi.org/10.3390/cancers18010120.